
BioCardia (NASDAQ: BCDA)
$1.34
(-3.6%)
-$0.05
Price as of October 10, 2025, 3:54 p.m. ET
BioCardia Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
BioCardia Company Info
BioCardia, Inc. is a clinical-stage biotherapeutic company. It engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.
News & Analysis
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.